Cargando…

Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials

BACKGROUND: High hyperdiploidy is the most common genetic subtype of childhood acute lymphoblastic leukaemia and is associated with a good outcome. However, some patients relapse and, given its prevalence, patients with high hyperdiploidy account for a large proportion of all relapses. We aimed to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enshaei, Amir, Vora, Ajay, Harrison, Christine J, Moppett, John, Moorman, Anthony V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567211/ https://www.ncbi.nlm.nih.gov/pubmed/34715050 http://dx.doi.org/10.1016/S2352-3026(21)00304-5

Ejemplares similares

Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
por: Schwab, Claire, et al.
Publicado: (2022)

Activity and toxicity of intramuscular 1000 iu/m(2) polyethylene glycol‐E. coli L‐asparaginase in the UKALL 2003 and UKALL 2011 clinical trials
por: Sidhu, Jasmeet, et al.
Publicado: (2022)

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
por: Moorman, Anthony V., et al.
Publicado: (2021)

Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial
por: Jenkinson, S, et al.
Publicado: (2016)

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials
por: Creasey, Thomas, et al.
Publicado: (2021)

Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol
por: Aslam, Sara, et al.
Publicado: (2021)

Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
por: Patel, B, et al.
Publicado: (2017)

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI
por: Halsey, Christina, et al.
Publicado: (2011)

Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial
por: Marks, David I, et al.
Publicado: (2022)

In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
por: Marks, David I, et al.
Publicado: (2022)

Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
por: Woodward, Eleanor L., et al.
Publicado: (2023)

Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia
por: Bashton, Matthew, et al.
Publicado: (2020)

HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial
por: Taylor, G M, et al.
Publicado: (2012)

Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform
por: Enshaei, Amir, et al.
Publicado: (2023)

Single nucleotide polymorphism array‐based signature of low hypodiploidy in acute lymphoblastic leukemia
por: Creasey, Thomas, et al.
Publicado: (2021)

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003
por: Lennard, Lynne, et al.
Publicado: (2015)

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018)

Is hyperdiploidy a favorable cytogenetics in adults with B‐lymphoblastic leukemia?
por: Chen, Zhining, et al.
Publicado: (2019)

Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children
por: Haas, Oskar A., et al.
Publicado: (2022)

Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
por: Sinclair, Paul B., et al.
Publicado: (2023)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Osteonecrosis in patients with acute lymphoblastic leukaemia: a national questionnaire study
por: Amin, Nadia Laila, et al.
Publicado: (2017)

Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia
por: Russell, Lisa J., et al.
Publicado: (2017)

Investigating CD99 Expression in Leukemia Propagating Cells in Childhood T Cell Acute Lymphoblastic Leukemia
por: Cox, Charlotte V., et al.
Publicado: (2016)

Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia
por: Escherich, Gabriele M, et al.
Publicado: (2011)

Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma
por: Yang, Naery, et al.
Publicado: (2018)

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
por: Lennard, Lynne, et al.
Publicado: (2014)

Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors
por: Diamanti, Paraskevi, et al.
Publicado: (2020)

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia
por: Gabriel, Alem S, et al.
Publicado: (2015)

Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities
por: López Villar, Elena, et al.
Publicado: (2014)

Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy
por: Karppinen, Santeri, et al.
Publicado: (2019)

The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy
por: Grobbelaar, Carle, et al.
Publicado: (2019)

Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
por: Lee, Jae Wook, et al.
Publicado: (2021)

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
por: Ryan, Sarra L., et al.
Publicado: (2023)

Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
por: Hahn, Seung Min, et al.
Publicado: (2022)

Temporal changes in incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council Trials, 1985–2001
por: Krishnan, Shekhar, et al.
Publicado: (2009)

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk
por: Vijayakrishnan, Jayaram, et al.
Publicado: (2019)

Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles
por: Li, Yingxiang, et al.
Publicado: (2013)

Reversal of glucocorticoid resistance in paediatric acute lymphoblastic leukaemia is dependent on restoring BIM expression
por: Toscan, Cara E., et al.
Publicado: (2020)

Paediatric pre‐B acute lymphoblastic leukaemia‐derived exosomes regulate immune function in human T cells
por: Gholipour, Elham, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ncalvibtoi7o0fqfrec86fc261